Growth Metrics

Insulet (PODD) Current Deferred Revenue (2016 - 2019)

Insulet filings provide 10 years of Current Deferred Revenue readings, the most recent being $1.2 million for Q1 2019.

  • On a quarterly basis, Current Deferred Revenue fell 57.46% to $1.2 million in Q1 2019 year-over-year; TTM through Mar 2019 was $1.2 million, a 57.46% decrease, with the full-year FY2018 number at $1.2 million, down 49.75% from a year prior.
  • Current Deferred Revenue hit $1.2 million in Q1 2019 for Insulet, up from $1.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.8 million in Q1 2018 to a low of $1.1 million in Q1 2017.
  • Median Current Deferred Revenue over the past 5 years was $1.9 million (2015), compared with a mean of $1.8 million.
  • Biggest five-year swings in Current Deferred Revenue: surged 216.67% in 2015 and later plummeted 57.46% in 2019.
  • Insulet's Current Deferred Revenue stood at $2.4 million in 2015, then fell by 19.53% to $1.9 million in 2016, then rose by 24.0% to $2.4 million in 2017, then crashed by 49.75% to $1.2 million in 2018, then grew by 0.93% to $1.2 million in 2019.
  • The last three reported values for Current Deferred Revenue were $1.2 million (Q1 2019), $1.2 million (Q4 2018), and $2.2 million (Q3 2018) per Business Quant data.